Director, Translational Development and Diagnostics - Hematology / Multiple Myeloma 10/9/2017

Celgene Summit, NJ

Summit, NJ
AJE Ref #
Job Classification
Full Time
Job Type
Company Ref #
Entry Level (0 - 2 years)


strong Other Locations: /strong US- NJ- Summit West P /p P Celgene R&D is at a critical and exciting phase of development. As it expands and integrates its portfolio, there is an opportunity for a dynamic and resourceful individual to lead our efforts in Translational Development at our site in Summit, NJ. /P P strong Translational Development at Celgene /strong /P P Translational Development is part of the Global Research and Early Development organization in Celgene and leads early stage clinical, pharmacological and translational research and development activities for the pipeline and supports late stage portfolio for regulatory, translational development and life cycle management. Translational Development is in the process of organizing a late translational group to support multiple disease areas of interest including Myeloma, Lymphoma, CLL and other hematological malignancies. This group will integrate scientific and business insights of multiple functions and lead the development of translational strategies at the franchise level and implement them in project teams to maximize the potential of Celgene drugs. /P P strong Summary /strong /P P Reporting to the Executive Director, Translational Development, the incumbent will be part of the translational group based in Summit NJ and will manage a small group of translational scientists who manage clinical projects and help develop translational strategies in Multiple Myeloma for approval or life-cycle management. Key responsibilities of this role are to act as key translational lead for the clinical programs and developing and executing translational strategy working with translational scientists and cross-functional disease team and thematic centers of excellence /P P strong Responsibilities /strong /P ul li Leads a group of translational scientists as a group lead and leads the translational development of portfolio of compounds translational annual goals and objectives for the myeloma group (for internal /external, translational collaboration, compound specific plans etc), ORQs, and is accountable for their progress monitoring in association with TD scientists /li li Assists in developing and maintaining group budget and workforce plan /li li Represents Translational Development in cross-functional project and strategy teams /li li Interfaces with commercial including early commercialization group and Medical Affairs to provide scientific support for cross-functional TD goals and support IIT studies /li li Manages and supervises preclinical collaboration strategy across the pipeline compounds for clinical assets /li li Assists in managing key strategic and/or collaborative projects along with TD scientists /li li Supports regulatory submissions, regulatory interactions, writes/reviews translational sections for regulatory response and answers to regulatory queries for the TD group /li li Interfaces with the diagnostic group for projects that need diagnostics development /li li Communicates regularly and prepares and makes presentations within the department and externally as required /li li Works with lab head to integrate translational research in the Summit lab of Celgene. /li /ul P /p